Stocks and Investing Stocks and Investing
Wed, December 14, 2022
Tue, December 13, 2022

Daniel Grosslight Maintained (TDOC) at Hold with Decreased Target to $33 on, Dec 13th, 2022


Published on 2024-10-28 00:33:13 - WOPRAI, Daniel Grosslight
  Print publication without navigation


Daniel Grosslight of Citigroup, Maintained "Teladoc Health, Inc." (TDOC) at Hold with Decreased Target from $36 to $33 on, Dec 13th, 2022.

Daniel has made no other calls on TDOC in the last 4 months.



There are 8 other peers that have a rating on TDOC. Out of the 8 peers that are also analyzing TDOC, 6 agree with Daniel's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jonathan Yong of "Credit Suisse" Maintained at Hold with Decreased Target to $30 on, Monday, October 31st, 2022
  • Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $32 on, Thursday, October 27th, 2022
  • Sandy Draper of "Guggenheim" Upgraded from Strong Sell to Hold on, Monday, October 24th, 2022
  • Jailendra Singh of "Truist Securities" Maintained at Hold with Decreased Target to $29 on, Friday, October 21st, 2022
  • George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $31 on, Tuesday, September 27th, 2022
  • Scott Schoenhaus of "Keybanc" Initiated at Hold on, Friday, September 16th, 2022


These are the ratings of the 2 analyists that currently disagree with Daniel


  • Robert Simmons of "DA Davidson" Maintained at Strong Buy with Decreased Target to $40 on, Tuesday, October 25th, 2022
  • Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $35 on, Wednesday, September 28th, 2022
Contributing Sources